Transmembrane topology of human glucose 6-phosphate transporter

J Biol Chem. 1999 May 14;274(20):13865-9. doi: 10.1074/jbc.274.20.13865.

Abstract

Glycogen storage disease type 1b is caused by a deficiency in a glucose 6-phosphate transporter (G6PT) that translocates glucose 6-phosphate from the cytoplasm to the endoplasmic reticulum lumen where the active site of glucose 6-phosphatase is situated. Using amino- and carboxyl-terminal tagged G6PT, we demonstrate that proteolytic digestion of intact microsomes resulted in the cleavage of both tags, indicating that both termini of G6PT face the cytoplasm. This is consistent with ten and twelve transmembrane domain models for G6PT predicted by hydropathy analyses. A region of G6PT corresponding to amino acid residues 50-71, which constitute a transmembrane segment in the twelve-domain model, are situated in a 51-residue luminal loop in the ten-domain model. To determine which of these two models is correct, we generated two G6PT mutants, T53N and S55N, that created a potential Asn-linked glycosylation site at residues 53-55 (N53SS) or 55-57 (N55QS), respectively. N53SS or N55QS would be glycosylated only if it is situated in a luminal loop larger than 33 residues as predicted by the ten-domain model. Whereas wild-type G6PT is not a glycoprotein, both T53N and S55N mutants are glycosylated, strongly supporting the ten-helical model for G6PT.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antiporters / chemistry*
  • Antiviral Agents / pharmacology
  • Blotting, Western
  • Cell Membrane / chemistry*
  • Humans
  • Mice
  • Molecular Sequence Data
  • Monosaccharide Transport Proteins / chemistry*
  • Protein Structure, Secondary
  • Rats
  • Tunicamycin / pharmacology

Substances

  • Antiporters
  • Antiviral Agents
  • Monosaccharide Transport Proteins
  • SLC37A4 protein, human
  • Slc37a4 protein, mouse
  • Slc37a4 protein, rat
  • glucose 6-phosphate(transporter)
  • Tunicamycin